As COVID Cuts Deadly Path Through Indiana Prisons, Inmates Say Symptoms Ignored
Since the start of the pandemic, prisoners and their families have contradicted state officials about the conditions inside Indiana prisons. Many inmates report they’ve had no way to protect themselves from close contact with other inmates and staff members. They believe contracting the coronavirus is inevitable.
When Prisons Are ‘Petri Dishes,’ Inmates Can’t Guard Against COVID-19, They Say
Indiana prisoners said they can’t protect themselves from the virus, as the governor resists calls to reduce overcrowding. “Scared for our lives,” said an inmate.
Conceived Through ‘Fertility Fraud,’ She Now Needs Fertility Treatment
Years ago, doctors sometimes lied about whose sperm they used for artificial inseminations. Could it happen now? Some argue regulation is weak in the multibillion-dollar fertility treatment industry.
Addiction Clinics Market Pricey, Unproven Treatments To Desperate Patients
An amino acid infusion called NAD is not approved by the FDA to treat addiction. Yet patients with addiction can be desperate enough to try it, at prices as high as $15,000.
Black Market For Suboxone Gives Some A Glimpse Of Recovery
Addiction experts argue that buprenorphine, which drug users buy on the street, actually saves lives because it is used in place of more dangerous substances, like heroin and fentanyl.
Desafío médico y moral: tratar a pacientes indocumentados con enfermedad renal terminal
Se estima que, en los Estados Unidos, hay 6.500 inmigrantes indocumentados con enfermedad renal en etapa terminal. Muchos de ellos terminan recibiendo diálisis en salas de emergencias.
Revertir una sobredosis no es complicado, encontrar el antídoto sí lo es
En abril, el Cirujano General de los Estados Unidos, Jerome Adams, emitió un aviso instando a más estadounidenses a aprender a usar naloxona en una emergencia.
Reversing An Overdose Isn’t Complicated, But Getting The Antidote Can Be
Last month, U.S. Surgeon General Jerome Adams urged more Americans to carry and learn to use naloxone, which can save someone from an opioid overdose. But the drug, brand-name Narcan, can be difficult to get and expensive.
Listen: Device Is Said To Ease Opioid Withdrawal, But Does The Evidence Support It?
A device called the Bridge is supposed to mitigate the misery of withdrawal sickness, but scientific evidence doesn’t yet show that it works.
Omissions On Death Certificates Lead To Undercounting Of Opioid Overdoses
Standards for how to investigate and report on overdoses vary widely across states and counties. As a result, opioid overdose deaths often go overlooked in the data reported to the federal government.
To Grow Market Share, A Drugmaker Pitches Its Product To Judges
Some drug courts offer participants a full range of evidence-based treatment, including medication-assisted treatment. Others don’t allow addiction medications at all. And some permit just one: Vivitrol.
Indiana’s Claims About Its Medicaid Experiment Don’t All Check Out
Indiana’s conservative take on Medicaid expansion is up for renewal in the home state of Vice President Mike Pence. But there are some discrepancies between the state’s application for renewal and facts about the program.
Trump’s Pick To Run Medicare And Medicaid Has Red State Policy Chops
Seema Verma is a consultant who was Vice President-elect Mike Pence’s health policy advisor when he was governor of Indiana, playing a key role in Medicaid expansion in that state.
Is 20-Something Too Late For A Guy To Get The HPV Vaccine?
A generation of young men missed out on the HPV vaccine. Now, 29-year-old journalist Jake Harper wonders if that’s putting him and other men at risk.
Deadly Opioid Overwhelms First Responders And Crime Labs in Ohio
Carfentanil, a potent variation on fentanyl, is being blamed for a wave of opioid overdoses. In Cincinnati, the coroner, crime lab and first responders are struggling to keep up.
Insurance Rules Can Hamper Recovery From Opioid Addiction
Medicaid and other health insurers require doctors to file time-consuming paperwork before allowing them to prescribe drugs that help people quit opioids. That delay fosters relapse, specialists say.
